J&J results top estimates, takes $13.6B tax charge
Johnson & Johnson reported adjusted quarterly profit and revenue slightly above analysts' expectations on Tuesday, as the healthcare company gained from strong demand for new drugs including cancer and psoriasis treatments.
0 comments:
Post a Comment